Results 141 to 150 of about 4,991,463 (296)
Racial disparities in anaemia associated with paediatric chronic kidney disease
British Journal of Haematology, EarlyView.
Manya Raina +3 more
wiley +1 more source
Risk Factors and Management of Gingival Enlargement: A Systematic Review and Meta‐Analysis
ABSTRACT Objective To identify risk factors/indicators of gingival enlargement (GE) and to summarise evidence for its management. Methods A systematic review was undertaken following PRISMA guidelines and divided into PECOTS and PICOTS questions, related to risk factors/indicators and treatment studies, respectively.
Luigi Nibali +5 more
wiley +1 more source
Subphenotypes of Sickle Cell Disease: A Guide to Targeting Treatment? [PDF]
Steinberg MH.
europepmc +1 more source
Erythrocyte ‘Feierzeit’ reaction: Novel filamentous and vesicular response to n‐butyl acetate
Abstract Human erythrocytes (red blood cells; RBCs) undergo spontaneous disassembly after several hours of exposure to n‐butyl acetate (nBA). Images of the morphological changes were captured in time‐lapse sequences using differential interference contrast (DIC) light microscopy.
Philip W. Kuchel
wiley +1 more source
Embedding a primary care provider in sickle cell teams improves sickle cell care. [PDF]
Della-Moretta S +6 more
europepmc +1 more source
ABSTRACT Objectives This study investigated the effect of nonsurgical periodontal therapy (NSPT) on periodontal clinical parameters, active‐matrix metalloproteinase‐8 (aMMP‐8), high sensitivity C‐reactive protein (hsCRP), and glycated hemoglobin (HbA1c), and their relationships in diabetes and prediabetes patients with periodontitis.
Kehinde Adesola Umeizudike +8 more
wiley +1 more source
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)
core
Hydroxyurea Use Among Medicaid Beneficiaries with Sickle Cell Disease in California and Georgia, 2006\u20132016 [PDF]
During 2006\u20132016, the use of hydroxyurea (HU) among Medicaid beneficiaries with sickle cell disease (SCD) who lived in California or Georgia increased. However, many beneficiaries with severe complications of SCD do not use HU.HU was approved by the
core
Perception among adult sickle cell patients on the use of herbal medicine in the management of sickle cell disease in Ghana: a qualitative study. [PDF]
Tumpi E +10 more
europepmc +1 more source

